6:
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L; MEDAL Steering Committee.
Lancet. 2006 Nov 18;368(9549):1771-81.
PMID: 17113426 [PubMed - indexed for MEDLINE]
Related Articles
12:
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.
Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.
PMID: 17083854 [PubMed - indexed for MEDLINE]
Related Articles
17:
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, Dixon ME, Polis AB, Mollen AJ, Geba GP; ADVANTAGE Study Group.
Ann Intern Med. 2003 Oct 7;139(7):539-46.
PMID: 14530224 [PubMed - indexed for MEDLINE]
Related Articles